Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orion Corp.

www.orion.fi

Latest From Orion Corp.

Keeping Track: Turalio, Nubeqa And Accrufer Mark Trio Of Novel Drug Approvals

The latest drug development news and highlights from our US FDA Performance Tracker.

Approvals Drug Review

Deal Watch: Sanofi Further Opts Out Of CNS Tie-Up With Voyager

Sanofi returns two partnered assets to Voyager, further unraveling 2015 deal. Celgene drops Mereo cancer candidate ahead of merger with Bristol, while Ultragenyx and Arcturus expand their joint rare disease efforts.

Business Strategies Commercial

Poland Switches from Rx-To-OTC Mylan's Duspatalin For IBS, Plus Orion's ED Treatment

Poland's medicines regulator has approved the switch of Mylan's Duspatalin and Orion's Valinger.
Prescription To Otc Switch Poland

J&J Sets Erleada On Real-Time Pathway For Castration-Sensitive Prostate Cancer Claim

Erleada is ninth product known to be using US FDA’s Real-Time Oncology Review pilot program, as shown in our comprehensive chart. 

 

Review Pathway Drug Review
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
    • Generic Drugs
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Finland
  • Parent & Subsidiaries
  • Orion Corp.
  • Senior Management
  • Timo Lappalainen , Pres., CEO & Chmn.
    Jari Karlson, CFO
    Satu Ahomaki, SVP, Commercial Operations
    Christer Nordstedt, MD, PhD, SVP, R&D
  • Contact Info
  • Orion Corp.
    Phone: (358) 10 4261
    Orionintie 1A 02200
    P.O. Box 65 Espoo, 02101
    Finland
Advertisement
Advertisement
UsernamePublicRestriction

Register